SEI Investments
JANX icon

SEI Investments’s Janux Therapeutics JANX Stock Holding History

SEI Investments’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,378
Closed -$502K – 2797
2024
Q4 		$502K Buy
+9,378
New +$496K ﹤0.01% 2183
2024
Q3 		– Sell
-8,958
Closed -$375K – 2727
2024
Q2 		$375K Sell
8,958
-176
-2% -$8.26K ﹤0.01% 2254
2024
Q1 		$344K Buy
+9,134
New +$199K ﹤0.01% 2250

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

SEI Investments's JANX Position: Q1 2025 in Review

SEI Investments sold out of Janux Therapeutics (JANX) in Q1 2025, closing a stake of 9,378 shares — an estimated $502K sold.

SEI Investments first reported a position in JANX in Q1 2024 and held it in 3 quarters. The position peaked at $502K in Q4 2024. 181 funds tracked by Wall St. Rank hold JANX as of Q1 2025.

  • SEI Investments reported no remaining Janux Therapeutics position as of Q1 2025 after selling out during the quarter.
  • SEI Investments sold 9,378 Janux Therapeutics shares in Q1 2025, an estimated $502K.
  • SEI Investments first reported a position in Janux Therapeutics in Q1 2024 and held it in 3 quarters.
  • SEI Investments's Janux Therapeutics position peaked at $502K in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2025.

Based on SEI Investments's 13F filing for Q1 2025, filed 13 May 2025.